Matches in DBpedia 2014 for { <http://dbpedia.org/resource/BEACOPP> ?p ?o. }
Showing items 1 to 32 of
32
with 100 items per page.
- BEACOPP abstract "BEACOPP is a chemotherapy regimen for treatment of Hodgkin's lymphoma developed by the German Hodgkin Study Group used for patients in Stages > II or early (IA or IB) with unfavorable risk factors. Patients typically receive treatment in cycles of 21 days with no drugs given on days 15-21.There also exists a more intensive regimen with cycles of 14 days. Usually a course of BEACOPP therapy consists of four, sometimes six to eight cycles, or in combination with ABVD. In some countries BEACOPP still is experimental, in others (e.g. Germany and Austria) it is a standard therapy. In the United States, ABVD (or Stanford V) is generally given instead, because BEACOPP was thought to induce more secondary neoplasias (such as leukemias), although the final results from the GHSG HD14 trial indicate that "therewere no overall differences in treatment-related mortality or secondary malignancies" of BEACOPP relative to ABVD.Some consider that the BEACOPP regimen is not generally given in the US for cost reasons: Twice as many infusion per cycle relative to ABVD; Requirement for G-CSF support, which is still under patent protection as Neupogen by Amgen in the US until Dec. 12, 2013, while Neupogen patent protection in the EU expired in 2008; Higher likelihood of adverse events requiring hospitalization, such as infection or acute toxicity; However, BEACOPP delivers approximately 7% points success relative to ABVD for early unfavorable Hodgkin's disease (as measured five-year freedom from treatment failure) and 12% points greater success relative to ABVD for advanced Hodgkin's disease (Stage IIB with risk factors or stages III and IV) as measured by seven-year freedom from treatment failure.BEACOPP Protocol Detailsm² = body surfacei.v. = intravenous".
- BEACOPP wikiPageExternalLink www.ghsg.org.
- BEACOPP wikiPageID "5828221".
- BEACOPP wikiPageRevisionID "603450069".
- BEACOPP hasPhotoCollection BEACOPP.
- BEACOPP subject Category:Chemotherapy_regimens.
- BEACOPP type Abstraction100002137.
- BEACOPP type Act100030358.
- BEACOPP type Activity100407535.
- BEACOPP type CancerTreatments.
- BEACOPP type Care100654885.
- BEACOPP type ChemotherapyRegimens.
- BEACOPP type Cognition100023271.
- BEACOPP type Content105809192.
- BEACOPP type Event100029378.
- BEACOPP type Idea105833840.
- BEACOPP type Plan105898568.
- BEACOPP type PsychologicalFeature100023100.
- BEACOPP type Regimen105909585.
- BEACOPP type Treatment100658082.
- BEACOPP type Work100575741.
- BEACOPP type YagoPermanentlyLocatedEntity.
- BEACOPP comment "BEACOPP is a chemotherapy regimen for treatment of Hodgkin's lymphoma developed by the German Hodgkin Study Group used for patients in Stages > II or early (IA or IB) with unfavorable risk factors. Patients typically receive treatment in cycles of 21 days with no drugs given on days 15-21.There also exists a more intensive regimen with cycles of 14 days. Usually a course of BEACOPP therapy consists of four, sometimes six to eight cycles, or in combination with ABVD.".
- BEACOPP label "BEACOPP".
- BEACOPP label "BEACOPP".
- BEACOPP sameAs BEACOPP.
- BEACOPP sameAs m.0f7t1t.
- BEACOPP sameAs Q473727.
- BEACOPP sameAs Q473727.
- BEACOPP sameAs BEACOPP.
- BEACOPP wasDerivedFrom BEACOPP?oldid=603450069.
- BEACOPP isPrimaryTopicOf BEACOPP.